WW
BEARISH
$9.29
Live
WW International, Inc. · NASDAQ
Target $37.0
(+298.3%)
$8.91
52W Range
$46.95
At a glance
Key valuation, profitability, growth, and risk metrics.
Updated Apr 24, 2026
Market cap
$92.87M
P/E
1.23
ROE
N/A
Profit margin
148.6%
Debt/Equity
1.47
Dividend yield
N/A
AI Analysis
AI-powered fundamental assessment
Confidence
85%
WW presents as a classic value trap; while the Piotroski F-Score is stable (5/9) and the stock trades at a massive discount to its Graham Number ($73.68) and Intrinsic Value ($53.06), the fundamental trajectory is alarming. Revenue is declining (-11.7% YoY), and the forward P/E is negative (-16.02), indicating expected losses. The extreme bearish price momentum (-65.6% over 1 year and -46.6% over 1 month) suggests the market is pricing in a structural decline that deterministic value formulas are failing to capture.
Key Strengths
Extremely low valuation multiples (P/S 0.13, P/B 0.29)
Strong Gross Margin of 71.72%
Stable Piotroski F-Score of 5/9
Healthy short-term liquidity (Current Ratio 1.69)
Significant gap between current price and analyst target price ($37.00)
Key Risks
Negative forward earnings expectations (Forward P/E -16.02)
Consistent revenue contraction (-11.7% YoY)
Severe price collapse (-69.4% in 6 months)
Operating margin is negative (-5.38%) despite high gross margins
High volatility in quarterly earnings surprises
AI Fair Value Estimate
Based on comprehensive analysis
$18.5
+99.1% above current price
Performance Snowflake
Multi-dimensional analysis across 5 key categories
Overall
34
Weak
80
20
15
55
0
AI Verdict
Value Trap
Key drivers: Revenue decline, Negative forward P/E, Extreme bearish technical trend, Divergence between book value and market price
Confidence
90%
Value
80/100
Ref P/E 1.23, Graham Number $73.68
Positives
- P/B of 0.29
- P/S of 0.13
- Trades far below Graham Number
Watchpoints
- Low P/E may be a reflection of deteriorating fundamentals rather than undervaluation
Future
20/100
Ref Revenue Growth -11.70%, Forward P/E -16.02
Positives
- High analyst target price
Watchpoints
- Negative forward P/E
- Declining revenue growth
Past
15/100
Ref 1Y Change -65.6%
Positives
- Occasional earnings beats
Watchpoints
- 1Y Return -65.6%
- YoY EPS Growth -281.2%
Health
55/100
Ref Piotroski F-Score 5/9
Positives
- Piotroski F-Score 5/9
- Current Ratio 1.69
Watchpoints
- Debt/Equity 1.47
- Negative operating margin
Dividend
0/100
Ref Dividend Yield N/A
Positives
No standout positives identified.
Watchpoints
- No dividend paid
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Current Price
$9.29
Analyst Target
$37.0
Upside/Downside
+298.3%
Multi-Horizon Performance vs Peers
Price momentum across 5Y → 1W horizons for WW and closest competitors.
Updated 2026-04-23
| Company | 5Y | 3Y | 1Y | 6M | 1M | 1W |
|---|---|---|---|---|---|---|
|
WW
WW International, Inc.
Primary
|
-65.6% | -65.6% | -65.6% | -69.4% | -46.6% | -12.9% |
|
BDSX
Biodesix, Inc.
Peer
|
-97.8% | -75.2% | -34.9% | +31.6% | +72.1% | +49.0% |
|
MXCT
MaxCyte, Inc.
Peer
|
-94.8% | -83.5% | -66.1% | -46.6% | +8.7% | +24.1% |
|
SERA
Sera Prognostics, Inc.
Peer
|
-80.7% | -29.7% | -32.4% | -28.1% | +20.4% | +16.8% |
|
GOSS
Gossamer Bio, Inc.
Peer
|
-95.6% | -66.2% | -57.8% | -85.5% | -26.7% | +0.4% |
WW
WW International, Inc.
Primary
5Y
-65.6%
3Y
-65.6%
1Y
-65.6%
6M
-69.4%
1M
-46.6%
1W
-12.9%
BDS
Biodesix, Inc.
Peer
5Y
-97.8%
3Y
-75.2%
1Y
-34.9%
6M
+31.6%
1M
+72.1%
1W
+49.0%
MXC
MaxCyte, Inc.
Peer
5Y
-94.8%
3Y
-83.5%
1Y
-66.1%
6M
-46.6%
1M
+8.7%
1W
+24.1%
SER
Sera Prognostics, Inc.
Peer
5Y
-80.7%
3Y
-29.7%
1Y
-32.4%
6M
-28.1%
1M
+20.4%
1W
+16.8%
GOS
Gossamer Bio, Inc.
Peer
5Y
-95.6%
3Y
-66.2%
1Y
-57.8%
6M
-85.5%
1M
-26.7%
1W
+0.4%
Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.
Historical Performance Trends
Long-term financial metrics and growth patterns
Revenue & Net Income
Profit & Operating Margins
Return on Equity (ROE)
Quarterly Revenue Growth
Historical data shows last 12 quarters (3 years)
Valuation Metrics
Key valuation ratios and pricing indicators
P/E Ratio
1.23
Forward P/E
-16.02
PEG Ratio
N/A
P/B Ratio
0.29
P/S Ratio
0.13
EV/Revenue
0.56
EV/EBITDA
2.7
Market Cap
$92.87M
Profitability
Profit margins and return metrics
Profit Margin
148.6%
Operating Margin
-5.38%
Gross Margin
71.72%
ROE
N/A
ROA
6.74%
Growth
Revenue and earnings growth rates
Revenue Growth
-11.7%
Earnings Growth
N/A
Q/Q Revenue Growth
N/A
Q/Q Earnings Growth
N/A
Financial Health
Balance sheet strength and liquidity metrics
Debt/Equity
1.47
Moderate
Current Ratio
1.69
Good
Quick Ratio
1.4
Good
Cash/Share
$16.03
Financial Statement Flow
Interactive flow visualization showing how money moves through the company Q4 2025
Revenue
$0.2B
Gross Margin
70.1%
Op. Margin
-7.9%
Net Margin
-3.6%
Operating CF
$-0.0B
CapEx
$-0.0B
Free Cash Flow
$-0.0B
FCF Yield
358%
Quarterly Earnings History
EPS performance vs analyst estimates
2026-05-07
$N/A
2026-03-16
$-0.58
+71.4% surprise
2025-11-06
$-5.76
-786.1% surprise
2025-08-11
$0.69
+2845.2% surprise
Healthcare Sector Comparison
Comparing WW against 528 companies in the Healthcare sector
(28 bullish, 156 neutral, 344 bearish)
P/E Ratio
1.23
This Stock
vs
81.62
Sector Avg
-98.5%
(Discount)
Profit Margin
148.6%
This Stock
vs
-16.56%
Sector Avg
-997.5%
(Weaker)
Debt to Equity
1.47
This Stock
vs
2.75
Sector Avg
-46.4%
(Less Debt)
Revenue Growth
-11.7%
This Stock
vs
131.76%
Sector Avg
-108.9%
(Slower)
Current Ratio
1.69
This Stock
vs
4.62
Sector Avg
-63.5%
(Weaker)
Similar Companies
Peer comparison within the same industry
| Company | AI Rating | Market Cap | P/E | ROE | Profit Margin | Price | |
|---|---|---|---|---|---|---|---|
|
WW
WW International, Inc.
|
BEARISH | $92.87M | 1.23 | -% | 148.6% | $9.29 | |
|
BDSX
Biodesix, Inc.
|
BEARISH | $93.92M | - | -302.6% | -49.3% | $11.74 | Compare |
|
MXCT
MaxCyte, Inc.
|
BEARISH | $94.19M | - | -23.6% | -135.1% | $0.88 | Compare |
|
SERA
Sera Prognostics, Inc.
|
BEARISH | $90.03M | - | -51.8% | -% | $2.3 | Compare |
|
GOSS
Gossamer Bio, Inc.
|
BEARISH | $87.21M | - | -% | -% | $0.37 | Compare |
WW
WW International, Inc.
BEARISH
Mkt Cap
$93M
P/E
1.2
ROE
-%
Price
$9.29
Recent Insider Trading
Insider buy and sell transactions from the last 6 months
| Date | Insider | Position | Transaction | Shares | Value |
|---|---|---|---|---|---|
| 2026-01-02 | BORNSTEIN JULIE D | Director | Stock Award | 1,166 | - |
| 2026-01-02 | SJOQVIST NIKOLAJ H | Director | Stock Award | 1,166 | - |
| 2026-01-02 | MASON MICHAEL B | Director | Stock Award | 1,166 | - |
| 2026-01-02 | HAWKS CARNEY | Director | Stock Award | 1,166 | - |
| 2025-12-19 | BORNSTEIN JULIE D | Director | Stock Award | 1,219 | - |
| 2025-12-19 | SJOQVIST NIKOLAJ H | Director | Stock Award | 1,219 | - |
| 2025-12-19 | MASON MICHAEL B | Director | Stock Award | 1,219 | - |
| 2025-12-19 | HAWKS CARNEY | Director | Stock Award | 1,219 | - |
| 2025-11-19 | HAWKS CARNEY | Director | Purchase | 29,057 | $643,464 |
BORNSTEIN JULIE D
Director
2026-01-02
1,166 shares
SJOQVIST NIKOLAJ H
Director
2026-01-02
1,166 shares
MASON MICHAEL B
Director
2026-01-02
1,166 shares
HAWKS CARNEY
Director
2026-01-02
1,166 shares
BORNSTEIN JULIE D
Director
2025-12-19
1,219 shares
SJOQVIST NIKOLAJ H
Director
2025-12-19
1,219 shares
MASON MICHAEL B
Director
2025-12-19
1,219 shares
HAWKS CARNEY
Director
2025-12-19
1,219 shares
HAWKS CARNEY
Director
2025-11-19
29,057 shares
·
$643,464
Insider transactions can signal confidence or concerns about company prospects
SEC Filings
Recent regulatory filings from the SEC EDGAR database
8-K/A
8-K
10-K
8-K
10-Q
Data sourced from SEC EDGAR. AI summaries generated automatically.
Wall Street Analysts
Professional analyst ratings and price targets
Consensus
NONE
3 analysts
Morgan Stanley
2026-01-15
Equal-Weight
Equal-Weight
Past News Coverage
Recent headlines mentioning WW from our newsroom.
Newest → oldest
No matching news yet.